Medigus: Charging Robotics Ltd. Completed First Technological Milestone of its Robot for Wireless Charging of Electric Vehicles
Medigus Ltd. (Nasdaq: MDGS) announced a significant breakthrough through its subsidiary, Charging Robotics Ltd., achieving a major proof of concept milestone for an autonomous robotic charging pad intended for wireless electric vehicle charging.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Medigus Ltd. (Nasdaq: MDGS) announced a significant breakthrough through its subsidiary, Charging Robotics Ltd., achieving a major proof of concept milestone for an autonomous robotic charging pad intended for wireless electric vehicle charging. The robot demonstrated its capability to locate and align optimally under vehicles for efficient charging. Future plans include integrating charging components onto the platform. This development aims to create an on-demand autonomous charging system that facilitates seamless charging anytime and anywhere.
Positive
- Successfully completed a proof of concept milestone for an autonomous robotic charging pad.
- Demonstrated the robot's ability to find and align under vehicles for efficient wireless charging.
- Aims to develop a seamless on-demand charging system for electric vehicles.
Negative
- None.
Details
News Market Reaction – MDGS
The recorded move for MDGS in the trading session of this news was +3.05%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Charging Robotics showed its robot can be directed to find a specific spot under the vehicle and optimize its position for high-efficiency wireless charging
OMER, Israel, April 29, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, announced today that Charging Robotics Ltd., a wholly owned subsidiary of Medigus, completed a first technological milestone in the proof of concept of its autonomous robotic charging pad for wireless charging of electric vehicles.
Charging Robotics completed the assembly and testing of its robot, showing it can be directed to find a specific spot under the vehicle and optimize its position for high-efficiency wireless charging. Charging Robotics intends to further integrate charging components onto the robotic platform to complete the proof of concept in full.
Charging Robotics is developing an on-demand autonomous charging system to be used anywhere, anytime. The wireless charging system being developed is intended to have self-aligning capabilities to electric vehicle battery chargers. The autonomous Wireless Power Transfer (WPT) technology, once developed, is intended to seamlessly and efficiently charge the vehicle upon demand, it will carry the Wireless Power Transfer from a charging station or charging truck, to a customer’s vehicle that needs electric charging.
About Medigus
Medigus is traded on the Nasdaq Capital Market. To learn more about Medigus’ advanced technology, please visit www.medigus.com.
Cautionary Note Regarding Forward Looking Statements
This press release may contain statements that are “Forward-Looking Statements,” which are based upon the current estimates, assumptions and expectations of Medigus’ management and its knowledge of the relevant market. Medigus has tried, where possible, to identify such information and statements by using words such as “anticipate,” “believe,” “envision,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,” “potential,” “will,” “would,” “could,” “should,” “continue,” “contemplate” and other similar expressions and derivations thereof in connection with any discussion of future events, trends or prospects or future operating or financial performance, although not all forward-looking statements contain these identifying words. For example, Medigus uses forward looking statements when it discusses the intention to integrate charging components onto the robotic platform, the completion of the proof of concept in full, that the on-demand autonomous charging system is intended to be used anywhere and anytime, that the WPT technology is intended to seamlessly and efficiently charge the vehicle upon demand and it will carry the WPT from charging station or charging truck, to a customer’s vehicle that needs electric charging, as well as the planned features and functionality of the WPT technology. These forward-looking statements represent Medigus’ expectations or beliefs concerning future events, and it is possible that the results described in this press release will not be achieved, due to inter alia the spread of COVID-19 as well as the restriction deriving therefrom and difficulties arising from the development and manufacture of wireless charging products. Nothing in the description herein should be understood or construed as an announcement of completed products or an existing proof of concept. By their nature, Forward-Looking Statements involve known and unknown risks, uncertainties and other factors which may cause future results of Medigus’ activity to differ significantly from the content and implications of such statements. Other risk factors affecting Medigus are discussed in detail in Medigus’ filings with the Securities and Exchange Commission. Forward-Looking Statements are pertinent only as of the date on which they are made, and Medigus undertakes no obligation to update or revise any Forward-Looking Statements, whether as a result of new information, future developments or otherwise. Neither Medigus nor its shareholders, officers and employees, shall be liable for any action and the results of any action taken by any person based on the information contained herein, including without limitation the purchase or sale of Medigus’ securities. Nothing in this press release should be deemed to be medical or other advice of any kind.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.